Two Sigma Securities’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$269K Buy
+14,656
New +$242K 0.02% 971
2024
Q4
– Sell
-15,268
Closed -$225K – 2683
2024
Q3
$225K Buy
+15,268
New +$239K ﹤0.01% 2037
2021
Q1
– Sell
-4,317
Closed -$232K – 1448
2020
Q4
$232K Buy
+4,317
New +$195K 0.01% 1267

Other funds holding NEO

Two Sigma Securities's NEO Position: Q3 2026 in Review

Two Sigma Securities opened a new position in NeoGenomics (NEO) in Q3 2026: 14,656 shares worth $269K. The stake represents 0.02% of the portfolio and ranks #971 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in NEO as recently as Q3 2024.

Two Sigma Securities first reported a position in NEO in Q4 2020 and has held it in 3 quarters since. 280 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

  • Two Sigma Securities held 14,656 shares of NeoGenomics worth $269K as of Q3 2026.
  • NeoGenomics was a new Two Sigma Securities position in Q3 2026.
  • NeoGenomics made up 0.02% of Two Sigma Securities's portfolio in Q3 2026, its #971 holding.
  • Two Sigma Securities first reported a position in NeoGenomics in Q4 2020 and has held it in 3 quarters since.
  • 280 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.